RU2011140574A - Способ растворения противогрибкового средства и композиции с высокой концентрацией противогрибкового средства, подходящие для нанесения на ногти - Google Patents

Способ растворения противогрибкового средства и композиции с высокой концентрацией противогрибкового средства, подходящие для нанесения на ногти Download PDF

Info

Publication number
RU2011140574A
RU2011140574A RU2011140574/15A RU2011140574A RU2011140574A RU 2011140574 A RU2011140574 A RU 2011140574A RU 2011140574/15 A RU2011140574/15 A RU 2011140574/15A RU 2011140574 A RU2011140574 A RU 2011140574A RU 2011140574 A RU2011140574 A RU 2011140574A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
composition according
terbinafine
antifungal agent
glycol
Prior art date
Application number
RU2011140574/15A
Other languages
English (en)
Russian (ru)
Inventor
Клер МАЛЛАР
Натали ВИЛЛЬКОКС
Original Assignee
Галдерма Ресерч Энд Девелопмент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Галдерма Ресерч Энд Девелопмент filed Critical Галдерма Ресерч Энд Девелопмент
Publication of RU2011140574A publication Critical patent/RU2011140574A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2011140574/15A 2009-03-06 2010-03-05 Способ растворения противогрибкового средства и композиции с высокой концентрацией противогрибкового средства, подходящие для нанесения на ногти RU2011140574A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20251609P 2009-03-06 2009-03-06
FR0951416A FR2942716B1 (fr) 2009-03-06 2009-03-06 Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
FR0951416 2009-03-06
US61/202,516 2009-03-06
PCT/EP2010/052817 WO2010100252A1 (en) 2009-03-06 2010-03-05 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail

Publications (1)

Publication Number Publication Date
RU2011140574A true RU2011140574A (ru) 2013-04-20

Family

ID=41056884

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011140574/15A RU2011140574A (ru) 2009-03-06 2010-03-05 Способ растворения противогрибкового средства и композиции с высокой концентрацией противогрибкового средства, подходящие для нанесения на ногти

Country Status (11)

Country Link
EP (1) EP2403476A1 (zh)
JP (1) JP2012519669A (zh)
KR (1) KR20110121702A (zh)
CN (1) CN102341092A (zh)
AU (1) AU2010220266A1 (zh)
BR (1) BRPI1006666A2 (zh)
CA (1) CA2753638A1 (zh)
FR (1) FR2942716B1 (zh)
MX (1) MX2011009093A (zh)
RU (1) RU2011140574A (zh)
WO (1) WO2010100252A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
KR101647545B1 (ko) * 2011-02-11 2016-08-10 모베르그 파르마 아베 신규 항진균 조성물
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
JP6611014B2 (ja) 2013-11-22 2019-11-27 ボシュ ヘルス アイルランド リミテッド 抗感染方法、抗感染組成物、および抗感染装置
PT3209319T (pt) * 2014-10-21 2021-09-24 Hexima Ltd Um método de tratamento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20080261986A1 (en) * 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug

Also Published As

Publication number Publication date
FR2942716A1 (fr) 2010-09-10
WO2010100252A1 (en) 2010-09-10
CN102341092A (zh) 2012-02-01
BRPI1006666A2 (pt) 2016-04-19
EP2403476A1 (en) 2012-01-11
CA2753638A1 (en) 2010-09-10
MX2011009093A (es) 2011-09-27
JP2012519669A (ja) 2012-08-30
AU2010220266A1 (en) 2011-09-08
FR2942716B1 (fr) 2011-04-15
KR20110121702A (ko) 2011-11-08

Similar Documents

Publication Publication Date Title
RU2011140574A (ru) Способ растворения противогрибкового средства и композиции с высокой концентрацией противогрибкового средства, подходящие для нанесения на ногти
ES2639727T3 (es) Método de acondicionamiento capilar y cutáneo
JP2016500095A5 (zh)
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
BRPI0608077A2 (pt) composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos
PH12017500136A1 (en) Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof
JP2016029094A (ja) 座瘡病変の治療のためのアダパレンと過酸化ベンゾイルとの組合せ
BR112014029757A2 (pt) composição contendo tensoativos do tipo aminoácido, betaínas e n-metil-n-acilglucaminas e tendo qualidade de espuma melhorada e maior viscosidade
BR112014024833A8 (pt) Produto farmacêutico veterinário mastigável macio, processo para a fabricação de um produto, uso de ácido pamóico ou um sal farmaceuticamente aceitável do mesmo, uso de um produto farmacêutico veterinário mastigável macio, e, composição farmacêutica veterinária mastigável macia.
CA2492976A1 (en) Solution for ungual and peri-ungual application
BR112015000088B1 (pt) composições farmacêuticas compreendendo rifamixinaa e aminoácidos, método de preparação e uso das mesmas
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
MY159577A (en) Oral care product and methods of use and manufacture thereof
BR112015025675A2 (pt) derivados do tipo bisamida de ácido dicarboxílico, uso dos mesmos, composição farmacêutica à base dos mesmos, e métodos para produzir derivados do tipo bisamida de ácido dicarboxílico
EP2646017A2 (en) Compounds and methods for skin repair
JP2013538853A5 (zh)
RU2016146938A (ru) Композиции, содержащие полимерную серу, и способы их применения
RS53982B1 (en) NEW ANTIGLIVIC COMPOSITIONS
RU2015106906A (ru) Местнодействующий жидкий агент для лечения дерматофитоза
BR112014001829A2 (pt) composições tópicas antioxidantes
BR112013031201A2 (pt) derivados de sulfonamida heterocíclicos, composição farmacêutica os compreendendo, uso, processo para a fabricação de (r)-n-(4,5-difluoro-6-((2-fluoro-4-iodofenil)amino)benzofuran-7-il)-1-(2,3-di-idroxipropil)ciclopropano-5 1-sulfonamida e kit
EA201591910A1 (ru) Стабильный раствор бромфенака
CY1122598T1 (el) Οφθαλμικη φαρμακευτικη συνθεση περιεχουσα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτης
JP2020011903A (ja) 外用組成物